![[logo] HealthTree Foundation](https://static.healthtree.org/icons/icon_spinner.svg){kind=icon}
Richard Furman, MD
Leukemia Specialist
Specialities: Acute Lymphoblastic Leukemia, Chronic Lymphocytic Leukemia
Spoken languages: English
![[logo] HealthTree Foundation](https://static.healthtree.org/logo_icon_only.svg){kind=icon}
more_vert
-min_30b108db-ffda-4f68-a776-427bed864ef4.jpg?alt=media&token=7fae0fe4-f10f-4e19-92af-f98b9353e954)
Clinical Expertise
- Acute Lymphoblastic Leukemia
- Chronic Lymphocytic Leukemia
About
Dr. Furman is Director of the CLL Research Center at Weill Cornell Medicine and a member of the Lymphoma/Myeloma Service in the Division of Hematology/Oncology. His area of focus is on the development of non-chemotherapeutic approaches to treating CLL, and has played an integral part in the development of ibrutinib and idelalisib.
Location
Weill Cornell Medical Center: 425 E 61st St 8th floor, New York, NY 10065, USA
Get the Latest Hepatosplenic T-Cell Lymphoma Updates, Delivered to You.
By subscribing to the HealthTree newsletter, you'll receive the latest research, treatment updates, and expert insights to help you navigate your health.